Why the study?
Exercise prescription for individuals with and without CVD should be scientifically-based yet adapted to the patient, requiring review of the clinical and physiologic basis for exercise prescription.
This clinical practice statement provides evidence-based recommendations for exercise prescription to optimize cardiovascular health in both general and specific patient populations.
Answers are grounded in this paper and cite their sources.
Informs exercise prescription in cardiovascular care; extends evidence synthesis into specific intensity, frequency, and duration targets.
The prescription of exercise for individuals with and without cardiovascular disease (CVD) should be scientifically-based yet adapted to the patient. This scientific statement reviews the clinical and physiologic basis for the prescription of exercise, with specific reference to the volume of physical activity (PA) and level of cardiorespiratory fitness (CRF) that confer significant and optimal cardioprotective benefits. Recommendations are provided regarding the appropriate intensity, frequency, and duration of training; the concept of MET-minutes per week; critical components of the exercise session (warm-up, conditioning phase, cool-down); methodologies for establishing the training intensity, including oxygen uptake reserve (V̇O₂R), target heart rate derivation and rating perceived exertion; minimum and goal intensities for exercise training; and, types of training activities, including resistance training, adjunctive lifestyle PA, marathon/triathlon training, and high-intensity interval training. In addition, we discuss the rationale for and value of exercise training programs for patients with peripheral artery disease, diabetes mellitus, and heart failure.
No takes yet. Share an insight, caveat, or question.
Franklin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: